State Injury Programs' Response to the Opioid Epidemic: The Role of CDC's Core Violence and Injury Prevention Program
| Autor: | Lindsey Myers, Sara Morman, Alan Dellapenna, Matt Laidler, Jolene DeFiore-Hyrmer, Lisa Millet, Angela J. Deokar |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Prescription drug
Best practice media_common.quotation_subject Psychological intervention Staffing Context (language use) Violence 01 natural sciences Article 03 medical and health sciences 0302 clinical medicine State (polity) Injury prevention medicine Humans 030212 general & internal medicine 0101 mathematics Epidemics media_common business.industry Health Policy 010102 general mathematics Public Health Environmental and Occupational Health Public relations medicine.disease Opioid-Related Disorders United States Core (game theory) Interinstitutional Relations Wounds and Injuries Medical emergency Centers for Disease Control and Prevention U.S Drug Overdose business State Government |
| Zdroj: | Journal of public health management and practice : JPHMP. 24 |
| ISSN: | 1550-5022 |
| Popis: | The Centers for Disease Control and Prevention's (CDC's) Core Violence and Injury Prevention Program (Core) supports capacity of state violence and injury prevention programs to implement evidence-based interventions. Several Core-funded states prioritized prescription drug overdose (PDO) and leveraged their systems to identify and respond to the epidemic before specific PDO prevention funding was available through CDC. This article describes activities employed by Core-funded states early in the epidemic. Four case examples illustrate states' approaches within the context of their systems and partners. While Core funding is not sufficient to support a comprehensive PDO prevention program, having Core in place at the beginning of the emerging epidemic had critical implications for identifying the problem and developing systems that were later expanded as additional resources became available. Important components included staffing support to bolster programmatic and epidemiological capacity; diverse and collaborative partnerships; and use of surveillance and evidence-informed best practices to prioritize decision-making. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|